4th Quarter - Report

NVG, LLC for ALEXION PHARMACEUTICALS

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Orphan Drug Tax Credit

LobbyistCovered position, as disclosed
LISA GERMAN FOSTER —
ANDREA LARUE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

FDA - rare and orphan disease issues; supply chain integrity (HR 3204 Drug Quality and Security Act and S. 959 Pharmacuetical Quality, Security and Accountability Act)

LobbyistCovered position, as disclosed
LISA GERMAN FOSTER —
ANDREA LARUE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3204 (113th), S. 959 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.